The New England Journal of Medicine
Inactive· since Apr 15, 2026
- 10
- days it ran
- 0
- relaunches
- 215
- EU reach
Ad copy
Does high-flow oxygen improve 28-day mortality? This large randomized trial provides important clarity.
Your trusted partner in practice
Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respirato...
LEARN MORE🪄Crush AI
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
